Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

Strategic Study of CAE >> 2018, Volume 20, Issue 6 doi: 10.15302/J-SSCAE-2018.06.010

Prospect of Medical Disruptive Technologies

1. Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100005, China;

2. Chinese Academy of Medical Sciences, Beijing 100005, China

Funding project:CAE Advisory Project “Strategic Research on Disruptive Technologies for Engineering Science and Technology” (2017-ZD-10) Received: 2018-11-01 Revised: 2018-11-16 Available online: 2018-12-31

Next Previous

Abstract

With the deep integration of modern information, materials and other technologies, the development of medical science and technology has been greatly promoted, and the way of disease diagnosis and treatment has undergone revolutionary changes. This paper mainly analyzes and evaluates five technical directions in tumor immunotherapy, gene editing technology, medical artificial intelligence, synthetic biology, and stem cell and translational medicine. Combining literature, think tank reports and expert opinions, the paper explores the direction of medical science and technology development. Finally, the paper puts forward the policy proposals including increasing investment in basic medical research, optimizing the top-level design of medical science and technology strategy, and improving policy and regulatory systems.

Figures

Fig.1

References

[ 1 ] Cao X T. Establishing the core base of medical science and technology innovation system [N]. People’s Daily, 2017-11-21 (13). Chinese.

[ 2 ] Qiu Z M, Wang L, Fu Y Y. Treatment progress in malignant tumors with immune checkpoint PD-1/PD-L1 inhibitor [J]. The Practical Journal of Cancer, 2018, 33(5): 868–870. Chinese. link1

[ 3 ] Liang P, Xu Y, Zhang X, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes [J]. Protein & Cell, 2015, 6(5):363–372. link1

[ 4 ] Kang X, He W, Huang Y, et al. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing [J]. Journal of Assisted Reproduction and Genetics,2016, 33(5): 581–588. link1

[ 5 ] Ma H, Marti-Gutierrez N, Park S W, et al. Correction of a pathogenicgene mutation in human embryos [J]. Nature, 2017, 548(7668): 413–419. link1

[ 6 ] Wang H X, Tian X Q, You M, et al. Application status, problemsand suggestions of artificial intelligence in medical field [J]. Soft Science of Health, 2018, 32(5): 3–5. Chinese. link1

[ 7 ] Iyiou Think Tank. Research report on artificial intelligence enablingmedical industry (2017) [R]. Beijing: Iyiou Think Tank, 2017. Chinese.

[ 8 ] Shao Y, Lu N, Wu Z, et al. Creating a functional single-chromosome yeast [J]. Nature, 2018, 560(7718): 331–335. link1

[ 9 ] Wang Y, Xu L, Shi H L. On development and trends of stem cells technology from perspective of patent [J]. Competitive Intelligence, 2017, 13(3): 43–50. Chinese. link1

[10] Augustyn J. Emerging science and technology trends: 2016—2045.A synthesis of leading forecasts [R]. USA: Office of the Deputy Assistant Secretary of the Army (Research & Technology), 2016. link1

[11] Li Z, Liu C P, Luo H. Elementary analysis the connotation and cultivation of disruptive technology—Focus on basic scientific research behind disruptive technologies [J]. Global Science, Technology and Economy Outlook, 2016, 31(10): 53– 61. Chinese. link1

Related Research